Loading...
Loading...
India's atorvastatin imports from PUERTO RICO total $641 across 1 shipments from 1 foreign suppliers. DKSH MALAYSIA SDN BHD leads with $641 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include TORRENT PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for atorvastatin โ a concentrated sourcing relationship with select suppliers from PUERTO RICO.

DKSH MALAYSIA SDN BHD is the leading Atorvastatin supplier from PUERTO RICO to India, with import value of $641 across 1 shipments. The top 5 suppliers โ DKSH MALAYSIA SDN BHD โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DKSH MALAYSIA SDN BHD | $641 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LIMITED | $641 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Atorvastatin suppliers from PUERTO RICO to India include DKSH MALAYSIA SDN BHD. The leading supplier is DKSH MALAYSIA SDN BHD with import value of $641 USD across 1 shipments. India imported Atorvastatin worth $641 USD from PUERTO RICO in total across 1 shipments.
India imported Atorvastatin worth $641 USD from PUERTO RICO across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Atorvastatin sourced from PUERTO RICO include TORRENT PHARMACEUTICALS LIMITED. The largest buyer is TORRENT PHARMACEUTICALS LIMITED with $641 in imports across 1 shipments.
The total value of Atorvastatin imports from PUERTO RICO to India is $641 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists